Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Medicines Biologic'

Medicines Biologic published presentations and documents on DocSlides.

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

  • min-jolicoeur
  • 0 Slides

Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...

Talking About Brain Health & Aging: The Basics

Talking About Brain Health & Aging: The Basics

  • tatyana-admore
  • 0 Slides

ACL is an operating division of the U.S. Departme...

The key principles of pharmacology

The key principles of pharmacology

  • danika-pritchard
  • 0 Slides

Pharmacodynamics. is the study of . the effect o...

Chemistry projects & presentations

Chemistry projects & presentations

  • sherrill-nordquist
  • 0 Slides

4. th. 9 Weeks final . overview. The purpose of ...

What type of complementary therapies are

What type of complementary therapies are

  • tawny-fly
  • 0 Slides

gynaecological. cancer patients . using and what...

Preventing Drug Abuse Legal and illegal drugs

Preventing Drug Abuse Legal and illegal drugs

  • tatyana-admore
  • 0 Slides

Vocabulary. Drug. . – a chemical substance tha...

Optimizing Use of Biological Agents in Ulcerative Colitis

Optimizing Use of Biological Agents in Ulcerative Colitis

  • tatyana-admore
  • 0 Slides

Introduction. Case 1: . What to Do When Conventio...

Good g overnance in the pharmaceutical

Good g overnance in the pharmaceutical

  • trish-goza
  • 0 Slides

sector. . Cécile . Macé. Department of Essenti...

Access to affordable and quality assured essential medicines

Access to affordable and quality assured essential medicines

  • ellena-manuel
  • 0 Slides

Gilles Forte. Policy. , Access and Use Team. Depa...

Improving access to controlled medicines

Improving access to controlled medicines

  • conchita-marotz
  • 0 Slides

Gilles . Forte. Coordinator, Policy, Access and U...

NHS West Lancashire CCG – Strategy, Vision & Operational Update

NHS West Lancashire CCG – Strategy, Vision & Operational Update

  • calandra-battersby
  • 0 Slides

Paul Kingan, Chief Finance Officer. 112,000 popul...

Advancing Patient Engagement through Coalition Partnerships

Advancing Patient Engagement through Coalition Partnerships

  • trish-goza
  • 0 Slides

2nd Annual . Optimizing Patient Adherence Confere...

Responsible and appropriate (rational) use of medicines

Responsible and appropriate (rational) use of medicines

  • phoebe-click
  • 0 Slides

Dr Jane Robertson. Policy, Access and Use Team, E...

Value of generic medicines

Value of generic medicines

  • conchita-marotz
  • 0 Slides

PARTNERSHIP. Medicines for Europe Vision 2020 . O...

Generating Information for Medicines Benefit Management:

Generating Information for Medicines Benefit Management:

  • natalia-silvester
  • 0 Slides

A Systems Framework. Dennis Ross-Degnan, ScD. Har...

Overview Antibiotics are precious life-saving medicines

Overview Antibiotics are precious life-saving medicines

  • debby-jeon
  • 0 Slides

Antimicrobial resistance is both a global and loc...

Access to essential medicines for NCDs

Access to essential medicines for NCDs

  • conchita-marotz
  • 0 Slides

WHO EMP and NVI Departments. Access to NCD essent...

All You Wanted to Know About the Drug FactS Label

All You Wanted to Know About the Drug FactS Label

  • tatyana-admore
  • 0 Slides

And more…. 1. What is the . Drug Facts Label. ?...

Economic characteristics

Economic characteristics

  • conchita-marotz
  • 0 Slides

of pharmaceuticals. .. Jamasoft2017. 1. Jamasoft2...

SADC Medicines Database (SMD)

SADC Medicines Database (SMD)

  • liane-varnes
  • 0 Slides

30 June 2016. Presentation Outline . Programme B...

B2 How medicines can be

B2 How medicines can be

  • liane-varnes
  • 0 Slides

sustainably and equitably financed. Summary Discu...

Overview of the African Medicines Regulatory

Overview of the African Medicines Regulatory

  • celsa-spraggs
  • 0 Slides

Harmonization and . African Medicines Agency. Mar...

The Future of HIV Treatment

The Future of HIV Treatment

  • myesha-ticknor
  • 0 Slides

Greg Perry. Melbourne – International AIDS Conf...

Improving access to medicines through local production:

Improving access to medicines through local production:

  • luanne-stotts
  • 0 Slides

Some New Development. I P C Meeting, Copenhagen (...

Local Production and A ccess to Medicines

Local Production and A ccess to Medicines

  • ellena-manuel
  • 0 Slides

EMP - Technical Briefing Seminar. . 1 November, ...

Review evidence to inform the health benefits package reform

Review evidence to inform the health benefits package reform

  • lois-ondreau
  • 0 Slides

in Vietnam. 1. Waranya Rattanavipapong. Yot Teera...

The International Pharmacopoeia

The International Pharmacopoeia

  • kittie-lecroy
  • 0 Slides

Dr Herbert Schmidt. Technologies, Standards and N...

Medicines benefits management policies and programs: updates

Medicines benefits management policies and programs: updates

  • giovanna-bartolotta
  • 0 Slides

Emmanuel Kwesi Eghan . Center . for Pharmaceutica...

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

  • natalia-silvester
  • 0 Slides

V. . Habiyambere. , . J. . Perriëns. , B. Dongmo...

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

  • tawny-fly
  • 0 Slides

T.U. . Federation of Chemical, Glass and Ceramic....

Regulatory capacity building and NDRA approvals of prequalified

Regulatory capacity building and NDRA approvals of prequalified

  • celsa-spraggs
  • 0 Slides

products. Milan . Smid. . Prequalification team ...

Opportunities & Challenges:

Opportunities & Challenges:

  • pasty-toler
  • 0 Slides

Expanding Access to Hepatitis C Treatment . Gregg...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

  • cheryl-pisano
  • 0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Procurement is a hot topic!

Procurement is a hot topic!

  • pamella-moone
  • 0 Slides

So is Supply Management – but for today we will...

WHO Prequalification Team – Need and contribution

WHO Prequalification Team – Need and contribution

  • debby-jeon
  • 0 Slides

Wednesday, 5 November . 2014. 13:35 – 15:45 . W...

An introduction to the work of Australia’s regulator of therapeutic goods

An introduction to the work of Australia’s regulator of therapeutic goods

  • luanne-stotts
  • 0 Slides

Therapeutic Goods Administration. Overview. Why d...

Developing Better Medicines at Lower

Developing Better Medicines at Lower

  • luanne-stotts
  • 0 Slides

Costs: The . Good Pharma Model. Speaker:. Donald ...

NEPAD Planning and Coordinating Agency

NEPAD Planning and Coordinating Agency

  • lois-ondreau
  • 0 Slides

Multiple-Stakeholder Partnerships for Medicines B...

Dr Samvel Azatyan Group Lead

Dr Samvel Azatyan Group Lead

  • lindy-dunigan
  • 0 Slides

Capacity Building and Harmonization Support. Regu...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

Copyright © 2024 DocSlides. All Rights Reserved